Corvus Pharmaceuticals, Inc. (CRVS) Net income 2016–2025
Corvus Pharmaceuticals, Inc. (CRVS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$15.3MFY2025 · since FY2016: -$36.4M → -$15.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.3M | +75.4% |
| FY2024 | -$62.3M | -130.7% |
| FY2023 | -$27.0M | +34.6% |
| FY2022 | -$41.3M | +4.5% |
| FY2021 | -$43.2M | -621.3% |
| FY2020 | -$6.0M | +87.2% |
| FY2019 | -$46.7M | +0.6% |
| FY2018 | -$46.9M | +15.7% |
| FY2017 | -$55.7M | -53.0% |
| FY2016 | -$36.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice